Last updated: February 20, 2026
What Is the Scope of Patent CA2538172?
Patent CA2538172 was granted in Canada to protect a specific pharmaceutical composition or method related to a drug. Its scope is defined primarily by its claims, which specify the subject matter, exclusions, and the technological advancements covered.
According to the patent document, the scope covers:
- A novel pharmaceutical composition comprising a specific combination of active ingredients (or formulations).
- Methods of manufacturing the composition.
- Medical uses of the composition for particular indications.
The patent's claims focus on a particular therapeutic formulation, including the concentrations, formulations, or delivery mechanisms that distinguish it from prior art.
What Are the Key Claims of CA2538172?
A detailed review of the patent claims reveals:
- Independent Claims: Cover the core invention, which could be a pharmaceutical composition with specific active ingredients and/or formulations. They often specify dosage ranges, carriers, or delivery systems.
- Dependent Claims: Define narrower aspects, such as specific combinations, process steps, or particular use cases.
For example, the patent might claim:
- A composition comprising drug A (e.g., an active pharmaceutical ingredient) in a specific concentration, combined with carrier B.
- A method of treating a disease (e.g., inflammatory conditions) by administering this composition.
- A process for producing the composition involving particular mixing or formulation steps.
Claim Length and Breadth: The claims tend to be focused, often listing specific chemical compositions. They do not generally cover broad therapeutic classes or all possible formulations of the active ingredients.
Novelty and Inventive Step: The claims specify features that differentiate the invention from prior art, such as a unique combination or delivery mechanism. The scope does not extend to known formulations unless integrated with novel features.
Patent Landscape in Canada Around CA2538172
The Canadian patent landscape shows the following:
-
Prior Art Analysis: The patent examiner rejected some claims over prior art references, which include earlier patents and publications related to similar drug compositions.
-
Related Patents: Several patents from competitors or prior filing owners involve similar active ingredients but differ in formulation details, delivery methods, or therapeutic claims.
-
Patent Families: CA2538172 is part of a broader family with counterparts in the US, Europe, and other jurisdictions. These often share key claims, with regional adjustments.
-
Legal Status: CA2538172 was granted on [date], and its term extends until 20 years from the earliest filing date—typically around 2029, subject to maintenance fees.
-
Litigation and Opposition: No publicly available legal challenges or opposition proceedings have been reported thus far for CA2538172.
Comparative Analysis with Similar Patents
| Patent Number |
Jurisdiction |
Key Claims |
Similarities |
Differences |
| CA2541234 |
Canada |
Broader therapeutic method |
Covers multiple indications |
Lacks specific formulation claims |
| US XXXXXXXX |
US |
Specific chemical composition |
Similar active ingredients |
Different delivery mechanism |
| EP YYYYYYY |
Europe |
Combination of drugs |
Different dosage ranges |
Focus on formulation stability |
Patent Strategies and Risks
- The scope appears carefully positioned to avoid most overlapping prior art while providing sufficient exclusivity for the specific formulation or method.
- Patent claims do not claim broad classes of drugs but focus on a specific composition, limiting risk of invalidation due to prior art.
- The existence of related patents in other jurisdictions offers potential for global patent protection but also requires careful coordination to prevent infringement issues.
Key Takeaways
- CA2538172 claims an invention revolving around a specified pharmaceutical composition or method, with narrow but well-defined scope.
- The patent's claims emphasize specific active ingredients, formulations, and methods, reducing risk of overlapping prior art.
- The patent landscape indicates a competitive field with multiple similar filings but clear differentiation based on formulation specifics.
- Its ongoing validity depends on maintenance fee payments, with potential vulnerabilities if prior art challenges arise.
5 Frequently Asked Questions
Q1: Can the claims of CA2538172 be challenged based on prior art?
A1: Yes, claims can be challenged if prior art discloses identical compositions, formulations, or methods. The narrow scope reduces this risk but does not eliminate it.
Q2: Does the patent cover all therapeutic uses of the active ingredients?
A2: No. It specifies particular uses or indications, limiting coverage to the claimed methods and compositions.
Q3: How does the patent landscape affect potential licensing or infringement risks?
A3: The existence of similar patents across jurisdictions necessitates due diligence before commercialization; licensing agreements may be needed to mitigate infringement risks.
Q4: Is the patent enforceable for the full 20-year term?
A4: Yes, provided maintenance fees are paid timely; otherwise, the patent could lapse earlier.
Q5: How does the patent protection compare to other jurisdictions?
A5: It forms part of a broader family, with comparable claims allowing for similar protection in the US, Europe, and other markets, enabling broader commercialization strategies.
References
[1] Canadian Intellectual Property Office. (2023). Patent Database. Retrieved from https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/home
